TrialBritish journal of clinical pharmacology2008

No significant effect of SLCO1B1 polymorphism on the pharmacokinetics of rosiglitazone and pioglitazone.

Annikka Kalliokoski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.